Souza, T. M. L., Pinho, V. D., Setim, C. F., Sacramento, C. Q., Marcon, R., Rodrigues, N. F., . . . Rabi, J. A. (2023). Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
Chicago Style CitationSouza, Thiago Moreno L., et al. Preclinical Development of Kinetin As a Safe Error-prone SARS-CoV-2 Antiviral Able to Attenuate Virus-induced Inflammation. 2023.
MLA CitationSouza, Thiago Moreno L., et al. Preclinical Development of Kinetin As a Safe Error-prone SARS-CoV-2 Antiviral Able to Attenuate Virus-induced Inflammation. 2023.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.